Personalised biologic DMARD assignment is still a pipedream. Given that the ACR 20/50/70 responses are not dissimilar regardless of your choice of the first targeted DMARD in RA patients with an... https://t.co/WorQaSgzgg
119 followers
6,927 followers
Right drug, right patient, right time: aspiration or future promise for biologics in rheumatoid arthritis? https://t.co/sYbYaKTR6Y
54 followers
Right drug, right patient, right time: aspiration or future promise for biologics in rheumatoid arthritis? https://t.co/Li19UuOXgU
682 followers
Right drug, right patient, right time: aspiration or future promise for biologics in RA? New paper out @ArthritisRes https://t.co/6UhGVZcCbQ